Skip to main content

Advertisement

SpringerLink
Log in

Ablation for Recurrent Hepatocellular Carcinoma: A Systematic Review of Clinical Efficacy and Prognostic Factors

  • Scientific Review
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Hepatocellular carcinoma (HCC) typically recurs following primary treatment. The primary objective of this systematic review was to evaluate the safety and efficacy of ablative therapies for recurrent HCC. The secondary objective was to identify any factors associated with prognosis following ablation for recurrent disease.

Methods

A systematic search of the literature published between January 2000 and December 2013 was undertaken using the PubMed, Medline and Scopus databases. Reference lists from selected studies were manually searched to ensure complete capture of any relevant data.

Results

A total of 19 studies were included in the review. The median age of patients undergoing ablation for recurrent HCC was 58 years (range 52–69 years) and 85 % of patients had cirrhosis (range 56–100 %). HCC recurred as a single nodule in 79 % of those treated with ablation (range 46–100 %). There were few significant complications associated with any form of ablation. Sufficient data were only available to allow analysis of survival outcomes following radiofrequency ablation (RFA). After RFA the median, 1, 3 and 5-year survivals were 84 % (73–99 %), 51 % (42–84 %) and 40 % (28–83 %), respectively. The only factor consistently associated with overall survival following ablation for recurrence was the alpha-fetoprotein (AFP) level.

Conclusion

Comparable survival figures from previously published systematic reviews suggest that hepatic resection is the most effective treatment for recurrent HCC. However, ablation can be a safe and effective option for the majority of patients with recurrent disease who are unsuitable for surgery. Elevated levels of AFP suggest a poorer prognosis following ablation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153–156

    Article  CAS  PubMed  Google Scholar 

  2. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745–750

    Article  CAS  PubMed  Google Scholar 

  3. Taylor-Robinson SD, Foster GR, Arora S et al (1997) Increase in primary liver cancer in the UK, 1979-94. Lancet 350:1142–1143

    Article  CAS  PubMed  Google Scholar 

  4. Capocaccia R, Sant M, Berrino F et al (2007) Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol 102:1661–1670

    Article  PubMed  Google Scholar 

  5. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  PubMed Central  PubMed  Google Scholar 

  6. Takenaka K, Kawahara N, Yamamoto K et al (1996) Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 131:71–76

    Article  CAS  PubMed  Google Scholar 

  7. Zhou Y, Sui C, Li B et al (2010) Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol 8:55

    Article  PubMed Central  PubMed  Google Scholar 

  8. Chan DL, Morris DL, Chua TC (2013) Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma—a systematic review. Surg Oncol 22:23–30

    Article  Google Scholar 

  9. Sugiura NTK, Ohto M, Okuda K et al (1982) Percutaneous intratumoral injection of ethanol under ultrasound imaging for treatment of small hepatocellular carcinoma. Acta Hepatol Jpn 24:1920

    Google Scholar 

  10. Chen MS, Li JQ, Zheng Y et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328

    Article  PubMed Central  PubMed  Google Scholar 

  11. Lu MD, Kuang M, Liang LJ et al (2006) Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 86:801–805

    PubMed  Google Scholar 

  12. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943

    Google Scholar 

  13. Howick J, Chalmers I, Glasziou P, et al. The Oxford Levels of Evidence http://www.cebm.net/mod_product/design/files/CEBM-Levels-of-Evidence-2.1.pdf. Accessed 10 May 2014

  14. Chan AC, Cheung TT, Fan ST et al (2013) Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma. Ann Surg 257:686–692

    Article  PubMed  Google Scholar 

  15. Chan AC, Chan SC, Chok KS et al (2013) Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? Liver Trans 19:411–419

    Article  Google Scholar 

  16. Chan AC, Poon RT, Cheung TT et al (2012) Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. World J Surg 36:151–156. doi:10.1007/s00268-011-1323-0

    Article  PubMed Central  PubMed  Google Scholar 

  17. Yang W, Chen MH, Yin SS et al (2006) Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence. AJR Am J Roentgenol 186:S275–S283

    Article  PubMed  Google Scholar 

  18. Yang W, Chen MH, Wang MQ et al (2009) Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment. Hepatol Res 39:231–240

    Article  CAS  PubMed  Google Scholar 

  19. Choi D, Lim HK, Rhim H et al (2007) Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol 14:2319–2329

    Article  PubMed  Google Scholar 

  20. Choi D, Lim HK, Kim MJ et al (2004) Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 230:135–141

    Article  PubMed  Google Scholar 

  21. Peng ZW, Zhang YJ, Liang HH et al (2012) Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 262:689–700

    Article  PubMed  Google Scholar 

  22. Lu MD, Yin XY, Xie XY et al (2005) Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br J Surg 92:1393–1398

    Article  PubMed  Google Scholar 

  23. Lee DH, Lee JM, Lee JY et al (2014) Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis. Cardiovasc Intervent Radiol 37:705–715

    Article  CAS  PubMed  Google Scholar 

  24. Liang HH, Chen MS, Peng ZW et al (2008) Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol 15:3484–3493

    Article  PubMed  Google Scholar 

  25. Nishikawa H, Osaki Y, Iguchi E et al (2012) Percutaneous radiofrequency ablation therapy for recurrent hepatocellular carcinoma. Anticancer Res 32:5059–5065

    PubMed  Google Scholar 

  26. Chen HW, Lai EC, Zhen ZJ et al (2011) Ultrasound-guided percutaneous cryotherapy of hepatocellular carcinoma. Int J Surg 9:188–191

    Article  CAS  PubMed  Google Scholar 

  27. Yin XY, Xie XY, Lu MD et al (2012) Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic model. Ann Surg Oncol 19:4300–4306

    Article  PubMed  Google Scholar 

  28. Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–1209

    Article  PubMed  Google Scholar 

  29. Kawano Y, Sasaki A, Kai S et al (2009) Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study. Eur J Surg Oncol 35:174–179

    Article  CAS  PubMed  Google Scholar 

  30. Ho CM, Lee PH, Shau WY et al (2012) Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities. Surgery 151:700–709

    Article  PubMed  Google Scholar 

  31. Eisele RM, Chopra SS, Lock JF et al (2013) Treatment of recurrent hepatocellular carcinoma confined to the liver with repeated resection and radiofrequency ablation: a single center experience. Technol Health Care 21:9–18

    CAS  PubMed  Google Scholar 

  32. Umeda Y, Matsuda H, Sadamori H et al (2011) A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection. World J Surg 35:170–177. doi:10.1007/s00268-010-0794-8

    Article  PubMed  Google Scholar 

  33. Poon RT, Fan ST, Lo CM et al (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229:216–222

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Takayasu K, Wakao F, Moriyama N et al (1992) Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors. Hepatology 16:906–911

    Article  CAS  PubMed  Google Scholar 

  35. Okazaki M, Yamasaki S, Ono H et al (1993) Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Hepatogastroenterology 40:320–323

    CAS  PubMed  Google Scholar 

  36. Peng ZW, Chen MS, Liang HH et al (2010) A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. Eur J Surg Oncol 36:257–263

    Article  PubMed  Google Scholar 

  37. Shibata T, Isoda H, Hirokawa Y et al (2009) Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 252:905–913

    Article  PubMed  Google Scholar 

  38. Chong C, Lai P. Treatment strategy for recurrent hepatocellular carcinoma. In: Julianov A (ed). Liver tumours. http://www.intechopen.com/books/liver-tumors/treatment-strategy-for-recurrent-hepatocellular-carcinoma. Accessed 10 May 2014

  39. Schumacher PA, Powell JJ, MacNeill AJ et al (2010) Multimodal therapy for hepatocellular carcinoma: a complementary approach to liver transplantation. Ann Hepatol 9:23–32

    PubMed  Google Scholar 

  40. Rossi S, Ravetta V, Rosa L et al (2011) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology 53:136–147

    Article  PubMed  Google Scholar 

  41. Xu HX, Lu MD, Xie XY et al (2005) Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients. Clin Radiol 60:1018–1025

    Article  PubMed  Google Scholar 

  42. Choi D, Lim HK, Rhim H et al (2007) Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17:684–692

    Article  PubMed  Google Scholar 

  43. Duan J, Liu K, Wu M et al (2011) Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: retrospective randomised control study. J Med Coll PLA 26:316–323

    Article  Google Scholar 

  44. Yan K, Chen MH, Yang W et al (2008) Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol 67:336–347

    Article  PubMed  Google Scholar 

  45. Liu Y, Zheng Y, Li S et al (2013) Percutaneous microwave ablation of larger hepatocellular carcinoma. Clin Radiol 68:21–26

    Article  CAS  PubMed  Google Scholar 

  46. Itoh S, Ikeda Y, Kawanaka H et al (2011) Efficacy of surgical microwave therapy in patients with unresectable hepatocellular carcinoma. Ann Surg Oncol 18:3650–3656

    Article  PubMed  Google Scholar 

  47. Itamoto T, Katayama K, Fukuda S et al (2001) Percutaneous microwave coagulation therapy for primary or recurrent hepatocellular carcinoma: long-term results. Hepatogastroenterology 48:1401–1405

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

There were no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Hepatobiliary and Pancreatic Surgery, University Hospitals of Leicester, Gwendolen Road, Leicester, LE5 4PW, UK

    S. C. Thomasset, A. R. Dennison & G. Garcea

Authors
  1. S. C. Thomasset
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. R. Dennison
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Garcea
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. C. Thomasset.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thomasset, S.C., Dennison, A.R. & Garcea, G. Ablation for Recurrent Hepatocellular Carcinoma: A Systematic Review of Clinical Efficacy and Prognostic Factors. World J Surg 39, 1150–1160 (2015). https://doi.org/10.1007/s00268-015-2956-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-015-2956-1

Keywords

Search

Navigation